Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernanda de Mello Malta

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Memorias Do Instituto Oswaldo Cruz|September 14, 2017
Basal core promoter and precore mutations among hepatitis B virus circulating in Brazil and its association with severe forms of hepatic diseasesSilvana Gama Florencio Chachá, Michele Soares Gomes-Gouvêa, Fernanda de Mello Malta, et al.
Revista Do Instituto De Medicina Tropical De Sao Paulo|October 5, 2022
Characterization of primary direct-acting antiviral (DAA) drugs resistance mutations in NS5A/NS5B regions of hepatitis C virus with genotype 1a and 1b from patients with chronic hepatitisAna Paula de Torres Santos, Vanessa Cristina Martins Silva, Maria Cássia Mendes-Corrêa, et al.
Infection and Drug Resistance|March 4, 2021
Prevalence and Pattern of Resistance in NS5A/NS5B in Hepatitis C Chronic Patients Genotype 3 Examined at a Public Health Laboratory in the State of São Paulo, BrazilAna Paula de Torres Santos, Vanessa Cristina Martins Silva, Maria Cássia Mendes-Corrêa, et al.
Revista De Saude Publica|May 11, 2017
Hepatitis C among blood donors: cascade of care and predictors of loss to follow-upSoraia Mafra Machado, Cesar de Almeida, João Renato Rebello Pinho, et al.
Annals of Hepatology|October 10, 2019
Sofosbuvir inhibits yellow fever virus in vitro and in patients with acute liver failureÉrica Araújo Mendes, Denise Regina Bairros de Pilger, Ana Catharina de Seixas Santos Nastri, et al.
Infection and Drug Resistance|November 23, 2018
Prevalence of resistance-associated substitutions to direct-acting antiviral agents in hemodialysis and renal transplant patients infected with hepatitis C virusRita Chelly Felix Tavares, Ana Cristina de Castro Amaral Feldner, João Renato Rebello Pinho, et al.
Journal of Medical Virology|November 12, 2024
Acute Hepatitis Related to Hepatitis E Virus Genotype 3f Infection in BrazilLeidiane B Ribeiro, Luciana A Reche, Ana C de Seixas Santos Nastri, et al.
Virology|April 2, 2016
Interferon lambda and hepatitis C virus core protein polymorphisms associated with liver cancerJoão Paulo Moreira, Fernanda de Mello Malta, Márcio Augusto Diniz, et al.
Memorias Do Instituto Oswaldo Cruz|May 23, 2019
Lipase and factor V (but not viral load) are prognostic factors for the evolution of severe yellow fever casesLuciana Vilas Boas Casadio, Ana Paula Moreira Salles, Fernanda de Mello Malta, et al.
Emerging Infectious Diseases|May 23, 2020
Sabiá Virus-Like Mammarenavirus in Patient with Fatal Hemorrhagic Fever, Brazil, 2020Fernanda de Mello Malta, Deyvid Amgarten, Ana Catharina de Seixas Santos Nastri, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Memorias Do Instituto Oswaldo Cruz|September 14, 2017
Basal core promoter and precore mutations among hepatitis B virus circulating in Brazil and its association with severe forms of hepatic diseasesSilvana Gama Florencio Chachá, Michele Soares Gomes-Gouvêa, Fernanda de Mello Malta, et al.
Revista Do Instituto De Medicina Tropical De Sao Paulo|October 5, 2022
Characterization of primary direct-acting antiviral (DAA) drugs resistance mutations in NS5A/NS5B regions of hepatitis C virus with genotype 1a and 1b from patients with chronic hepatitisAna Paula de Torres Santos, Vanessa Cristina Martins Silva, Maria Cássia Mendes-Corrêa, et al.
Infection and Drug Resistance|March 4, 2021
Prevalence and Pattern of Resistance in NS5A/NS5B in Hepatitis C Chronic Patients Genotype 3 Examined at a Public Health Laboratory in the State of São Paulo, BrazilAna Paula de Torres Santos, Vanessa Cristina Martins Silva, Maria Cássia Mendes-Corrêa, et al.
Revista De Saude Publica|May 11, 2017
Hepatitis C among blood donors: cascade of care and predictors of loss to follow-upSoraia Mafra Machado, Cesar de Almeida, João Renato Rebello Pinho, et al.
Annals of Hepatology|October 10, 2019
Sofosbuvir inhibits yellow fever virus in vitro and in patients with acute liver failureÉrica Araújo Mendes, Denise Regina Bairros de Pilger, Ana Catharina de Seixas Santos Nastri, et al.
Infection and Drug Resistance|November 23, 2018
Prevalence of resistance-associated substitutions to direct-acting antiviral agents in hemodialysis and renal transplant patients infected with hepatitis C virusRita Chelly Felix Tavares, Ana Cristina de Castro Amaral Feldner, João Renato Rebello Pinho, et al.
Journal of Medical Virology|November 12, 2024
Acute Hepatitis Related to Hepatitis E Virus Genotype 3f Infection in BrazilLeidiane B Ribeiro, Luciana A Reche, Ana C de Seixas Santos Nastri, et al.
Virology|April 2, 2016
Interferon lambda and hepatitis C virus core protein polymorphisms associated with liver cancerJoão Paulo Moreira, Fernanda de Mello Malta, Márcio Augusto Diniz, et al.
Memorias Do Instituto Oswaldo Cruz|May 23, 2019
Lipase and factor V (but not viral load) are prognostic factors for the evolution of severe yellow fever casesLuciana Vilas Boas Casadio, Ana Paula Moreira Salles, Fernanda de Mello Malta, et al.
Emerging Infectious Diseases|May 23, 2020
Sabiá Virus-Like Mammarenavirus in Patient with Fatal Hemorrhagic Fever, Brazil, 2020Fernanda de Mello Malta, Deyvid Amgarten, Ana Catharina de Seixas Santos Nastri, et al.
Pageof 5